NCT02398773 2026-03-18
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT07112053 2026-03-09
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
NCT05659797 2026-02-27
FES BPET-DBT in Newly Diagnosed Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting